Search | OpenScholar

Search results

374 results found

Pramipexole-induced somnolence and episodes of daytime sleep. Movement Disorders 2000;15:658-663.

Publication: Journal Article

Hauser, RA, L Gauger, WM Anderson, and TA Zesiewicz. 2000. “Pramipexole-Induced Somnolence and Episodes of Daytime Sleep. Movement Disorders 2000;15:658-663.”. Movement Disorders.

Long-term evaluation of bilateral fetal nigral transplantation in Parkinson’s disease. Arch Neurol 1999;56:179-187.

Publication: Journal Article

Hauser, RA. 1999. “Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson’s Disease. Arch Neurol 1999;56:179-187.”. Arch Neurol.

Use of placebo surgery in controlled trials of cellular-based therapy for Parkinson’s disease. NEJM 1999; 341:988-992.

Publication: Journal Article

Freeman, TB, DE Vawter, PE Leaverton, JH Godbold, RA Hauser, CG Goetz, and CW Olanow. 1999. “Use of Placebo Surgery in Controlled Trials of Cellular-Based Therapy for Parkinson’s Disease. NEJM 1999; 341:988-992.”. NEJM.

Delayed stimulation-induced thalamic ataxia syndrome. Neurology 1998:50:1184-1185.

Publication: Journal Article

Hauser, RA, J Friedlander, DA Smith, and MF Nolan. 1998. “Delayed Stimulation-Induced Thalamic Ataxia Syndrome. Neurology 1998:50:1184-1185.”. Neurology.

A pilot evaluation of the tolerability, safety and efficacy of tolcapone alone, and in combination with oral selegiline, in untreated Parkinson’s disease patients. Movement Disorders 1998;13:643-647.

Publication: Journal Article

Hauser, RA, E Molho, H Shale, S Pedder, EE Dorflinger, and Tolcapone De Novo Study Group. 1998. “A Pilot Evaluation of the Tolerability, Safety and Efficacy of Tolcapone Alone, and in Combination With Oral Selegiline, in Untreated Parkinson’s Disease Patients. Movement Disorders 1998;13:643-647.”. Movement Disorders.

Initial experience with electroconvulsive therapy for progressive supranuclear palsy. Movement Disorders 1994;9:467-469.

Publication: Journal Article

Hauser, RA, and R Trehan. 1994. “Initial Experience With Electroconvulsive Therapy for Progressive Supranuclear Palsy. Movement Disorders 1994;9:467-469.”. Movement Disorders.

The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular CSF L-dopa levels and clinical responses. Neurology 1993;43:1704-1708.

Publication: Journal Article

Woodward, WR, CW Olanow, RM Beckner, RA Hauser, LL Gauger, JM Cedarbaum, and J Nutt. 1993. “The Effect of L-Dopa Infusions With and Without Phenylalanine Challenges in Parkinsonian Patients: Plasma and Ventricular CSF L-Dopa Levels and Clinical Responses. Neurology 1993;43:1704-1708.”. Neurology.

Effective Parkinson’s treatment. An update on strategy. Senior patient. 1990;2:26-31.

Publication: Journal Article

Hauser, RA, and CW Olanow. 1990. “Effective Parkinson’s Treatment. An Update on Strategy. Senior Patient. 1990;2:26-31.”. Senior Patient.

USF Parkinson's Disease and Movement Disorders Center

Parkinson’s disease, clinical trials, treatment, evaluation, Robert Hauser, Botox, Movement Disorder, tremor, cervical dystonia, blepharospasm, hemifacial spasm

Gary's Story: An Elusive Diagnosis - Parkinson's

News: October 23, 2024